Mariana Spitz

Dr. Mariana Spitz


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2023 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
OBOrlando G. P. Barsottini
Orlando G. P. Barsottini
MMMarianna Pinheiro Moraes de Moraes
Marianna Pinheiro Moraes de Moraes
PFPedro Henrique Almeida Fraiman
Pedro Henrique Almeida Fraiman
VMVictor Hugo Rocha Marussi
Victor Hugo Rocha Marussi
ASAlexander Wagner Silva De Souza
Alexander Wagner Silva De Souza
MSMariana Spitz
Mariana Spitz
Sjogren's syndrome (SS) is a complex autoimmune disease characterized by lymphocytic infiltration of salivary and lacrimal glands, resulting in sicca symptoms. Additionally, SS presents with neurological manifestations that significantly impact the nervous system. This review aims to provide a comprehensive overview of the neurological aspects of SSj, covering both the peripheral and central nervous system involvement, while emphasizing diagnosis, treatment, and prognosis.

10 November 2014 in Journal of Child Neurology
Verified
Journal Article
Closed access
JAJosé Henrique W. Aquino
José Henrique W. Aquino
MSMariana Spitz
Mariana Spitz
JPJoão Santos Pereira
João Santos Pereira
Chorea may be secondary to hyperosmolar nonketotic hyperglycemia, but such situation has rarely been described in adolescents, particularly as the initial and single manifestation of type 1 diabetes. We describe a case of a previously healthy 14-year-old girl with sudden onset of choreic movements on her left upper and lower limbs. Brain computed tomography (CT) and magnetic resonance imaging (MRI) revealed an area of hyperdensity/hyperintensity affecting the right striatum. Blood glucose was 349 mg/dL. Despite adequate glucose control, the involuntary movements persisted and haloperidol, later substituted with valproate, was prescribed, with satisfactory but not complete resolution of the chorea. In 2 other occasions, when the patient had an infection and subsequent hyperglycemia, the chorea relapsed. Although not common, hyperglycemia must be considered in the differential diagnosis of acute hemichorea-hemiballismus in children and adolescents, particularly because it is a potentially reversible cause.

1 March 2022 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
RSRoberta Arb Saba
Roberta Arb Saba
DMDébora Palma Maia
Débora Palma Maia
FCFrancisco Eduardo Costa Cardoso
Francisco Eduardo Costa Cardoso
VBVanderci Borges
Vanderci Borges
LALuiz Augusto F. Andrade
Luiz Augusto F. Andrade
MCMarcus Vinicius Della Colletta
Marcus Vinicius Della Colletta
The treatment of Parkinson's disease (PD) is challenging, especially since it is considered highly individualized. The Brazilian Academy of Neurology has recognized the need to disseminate knowledge about the management of PD treatment, adapting the best evidence to the Brazilian reality. Thus, the main published treatment guidelines were reviewed based on the recommendations of group from the Movement Disorders Scientific Department of the Brazilian Academy of Neurology.

1 February 2016 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
RMRoberta K.J.V. Manhães
Roberta K.J.V. Manhães
MSMariana Spitz
Mariana Spitz
LVLuiz Felipe Vasconcellos
Luiz Felipe Vasconcellos

1 July 2021 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
CGClecio Godeiro
Clecio Godeiro
Carina FrançaCarina França
Carina França
RCRafael Bernhart Carra
Rafael Bernhart Carra
FSFelipe Saba
Felipe Saba
RSRoberta Saba
Roberta Saba
RCRubens Gisbert Cury
Rubens Gisbert Cury
Background: Noninvasive stimulation has been widely used in the past 30 years to study and treat a large number of neurological diseases, including movement disorders. Objective: In this critical review, we illustrate the rationale for use of these techniques in movement disorders and summarize the best medical evidence based on the main clinical trials performed to date. Methods: A nationally representative group of experts performed a comprehensive review of the literature in order to analyze the key clinical decision-making factors driving transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) in movement disorders. Classes of evidence and recommendations were described for each disease. Results: Despite unavoidable heterogeneities and low effect size, TMS is likely to be effective for treating motor symptoms and depression in Parkinson’s disease (PD). The efficacy in other movement disorders is unclear. TMS is possibly effective for focal hand dystonia, essential tremor and cerebellar ataxia. Additionally, it is likely to be ineffective in reducing tics in Tourette syndrome. Lastly, tDCS is likely to be effective in improving gait in PD. Conclusions: There is encouraging evidence for the use of noninvasive stimulation on a subset of symptoms in selected movement disorders, although the means to optimize protocols for improving positive outcomes in routine clinical practice remain undetermined. Similarly, the best stimulation paradigms and responder profile need to be investigated in large clinical trials with established therapeutic and assessment paradigms that could also allow genuine long-term benefits to be determined.

1 February 2017 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
LVLuiz Felipe Rocha Vasconcellos
Luiz Felipe Rocha Vasconcellos
PMPhilippe Joaquim Oliveira Menezes Macêdo
Philippe Joaquim Oliveira Menezes Macêdo
JFJéssyca Botelho Franck
Jéssyca Botelho Franck
VTVitor Tumas
Vitor Tumas
WJWilson Marques Júnior
Wilson Marques Júnior
MSMariana Spitz
Mariana Spitz